Related Experiment Videos
Drug usage review of cefamandole at a teaching hospital
Abstract:
A drug usage audit of cefamandole was conducted at a 900-bed teaching hospital. Health records of all in-patients receiving cefamandole during a three-month period (November 1, 1985 to January 31, 1986) were retrospectively reviewed. Treatment of lower respiratory tract infections accounted for 35 (44%) of the 79 treatment courses examined. Surgical antimicrobial prophylaxis for cardiovascular procedures involved 26 (33%) courses of therapy and 15 (19%) courses were associated with biliary tract procedures. The three remaining treatment courses (4%) included therapy for septicemia, orthopedic surgery prophylaxis, and a leg ulcer. Twenty-eight percent of all treatment courses were deemed to be appropriate. Thirty-two percent were considered controversial, and 40 percent inappropriate. The majority of the suboptimal use identified involved prescribing cefamandole for cardiovascular surgery prophylaxis. The role of cefamandole in the acute hospital setting is reviewed with reference to other available first, second and third-generation cephalosporins. General recommendations for its use are outlined.
Insights
A drug audit found 40% of cefamandole use was inappropriate, primarily in cardiovascular surgery prophylaxis. This highlights the need for revised guidelines for this antibiotic in hospitals.
Area of Science:
- Pharmacology
- Infectious Diseases
- Hospital Pharmacy
Background:
- Cefamandole is a second-generation cephalosporin antibiotic.
- Drug usage audits are crucial for optimizing antibiotic stewardship.
- Evaluating antibiotic use in acute care settings is essential for patient safety and resource management.
Purpose of the Study:
- To conduct a drug usage audit of cefamandole.
- To assess the appropriateness of cefamandole prescribing patterns.
- To review the role of cefamandole in comparison to other cephalosporins and provide usage recommendations.
Main Methods:
- Retrospective review of inpatient health records over a three-month period.
- Analysis of 79 treatment courses of cefamandole.
- Categorization of usage as appropriate, controversial, or inappropriate.
Main Results:
- Lower respiratory tract infections (44%) and surgical prophylaxis (cardiovascular 33%, biliary 19%) were primary indications.
- Only 28% of cefamandole treatment courses were deemed appropriate.
- 40% of usage was inappropriate, with cardiovascular surgery prophylaxis being the most common issue.
Conclusions:
- Significant inappropriate use of cefamandole was identified, particularly for cardiovascular surgery prophylaxis.
- The study underscores the need for stricter guidelines and improved prescribing practices for cefamandole.
- Recommendations for optimal cefamandole use in acute hospital settings are provided.